Sponsor or institution
Clinical trials and research at The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
As of November 12, 2026, Find a Trial lists 59 clinical trials run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School that are recruiting, in China. 1 was first registered in the last 30 days. By phase: Phase 2 (16), Phase 3 (4), Phase 1 (4), Phase 1/2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 59Clinical trials
- 1New in 30 days
- 1Country
Newest trials
All recruiting trials (59)
-
Acupuncture plus vitamin B12 for diabetic heart nerve damage
This study tests whether adding acupuncture to standard care and vitamin B12 can help adults with type 2 diabetes who have damaged the nerves that control the heart.
-
Bone marrow cells plus Bio-Oss graft for repairing severe jawbone defects
This study tests whether using a patient’s own bone marrow–derived mononuclear cells mixed with Bio-Oss graft can repair severe maxillofacial bone defects in adults aged 18-60.
-
Sintilimab with NALIRIFOX or GP as first-line treatment for metastatic biliary tract cancer
This study tests whether adding sintilimab to either NALIRIFOX or gemcitabine‑cisplatin can help people with metastatic biliary tract cancer who have not had prior systemic therapy.
-
Liposomal irinotecan with 5-FU/LV and sintilimab plus SBRT for unresectable biliary tract cancer
This trial tests whether combining liposomal irinotecan, 5-FU/LV, and sintilimab, followed by SBRT, can help patients with unresectable locally advanced biliary tract cancer become eligible for surgery or slow disease progression.
-
Ipsilateral vs Bilateral Biopsy for Prostate Cancer Diagnosis using MRI/Ultrasound Fusion
This study tests whether taking biopsy samples from only the same side as a MRI-detected lesion is as good as taking samples from both sides in men who are biopsy-naive and have a suspicious unilateral lesion.
-
AI-assisted remote insulin pump optimization for people with type 1 diabetes
This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.
-
Rezvilutamide as adjuvant therapy after radical prostatectomy for high-risk prostate cancer
This study tests whether switching to rezvilutamide after prostatectomy helps high-risk patients see fewer recurrences.
-
Metformin to improve heart function after LVAD placement
This trial tests whether metformin helps heart function after LVAD implantation compared with placebo in adults with LVADs.
-
VR-based cognitive training for adults with type 2 diabetes and mild cognitive impairment
A 40-person randomized study in adults with type 2 diabetes and mild cognitive impairment tests whether a VR-based cognitive training program with diabetes self-management beats traditional paper-and-pencil cognitive training.
-
Liver Inflammation Index test for MASH in adults with T2DM and MAFLD
This study tests a Liver Inflammation Index to see if it can identify MASH in adults who have both type 2 diabetes and MAFLD.
-
Transcutaneous auricular vagus nerve stimulation plus lifestyle for poor weight-loss responders
This study tests whether adding taVNS to lifestyle changes helps overweight or obese adults who lost at most 5% weight after 12 weeks of diet and exercise.
-
Prophylactic antibiotics to prevent surgical infections after hepatobiliary surgery in high-resistance settings
This study tests whether giving piperacillin-tazobactam before surgery can reduce surgical site infections in adults undergoing hepatobiliary operations in areas with high antibiotic resistance, compared with the standard cefuroxime approach.
-
Transcutaneous auricular vagus nerve stimulation added to tirzepatide for poor weight loss responses
This study tests whether adding taVNS to tirzepatide helps overweight or obese people who have not lost more than 10% of their weight after 12 weeks of tirzepatide.
-
Personalized beta-lactam dosing in cirrhosis patients with bacterial infections
This study tests whether tailoring beta-lactam dosing based on patient liver disease and drug levels can help people with cirrhosis and bacterial infections.
-
Validating a risk score for MDRGNB infection in ICU patients
This study tests whether a previously developed risk score can predict MDRGNB infection in adults admitted to ICUs across multiple centers.
-
Machine learning helps predict head and neck cancer risk from patient data and images
Researchers are testing a deep learning model to see if AI can predict the risk of head and neck cancer in adults using clinical data and laryngoscopic images.
-
Anricfen for pain relief and recovery after pancreaticoduodenectomy
This will try a short course of IV Anricfen in adults after pancreaticoduodenectomy to see if it reduces pain and speeds recovery.
-
Ferumoxytol-enhanced MR venography for people with venous disease
This trial will test whether ferumoxytol, an iron-based MRI contrast agent, produces clear venous images in adults with suspected or confirmed venous disease.
-
Brain and metabolic responses to different macronutrients in people with obesity
This trial will test whether three small, isocaloric liquid meals (glucose, fat, or protein) change brain activity and blood metabolites in adults with obesity and healthy-weight adults.
-
Long-term outcomes after LVAD implantation for end-stage heart failure
We will follow adults with end-stage heart failure who get an LVAD to see if they live longer and to record complications and hospital visits over the next 3–5 years.
-
KRAS neoantigen nanovaccine to help prevent recurrence after colorectal or pancreatic cancer surgery
This trial tests a KRAS-targeting nanovaccine made from engineered Lactococcus lactis membranes as adjuvant therapy for adults with resected colorectal or pancreatic cancer who have specific KRAS mutations.
-
XH001 plus personalized neoantigen vaccine–induced T-cell therapy for advanced stomach cancer
This trial tests whether combining XH001 with a personalized neoantigen vaccine and vaccine-induced tumor-specific T cells is safe and can shrink tumors in adults with advanced gastric (stomach) cancer.
-
Fat-derived cell treatment for thin uterine lining and intrauterine adhesions
This trial will try using a patient's own fat-derived stromal vascular fraction infused into the uterus to see if it thickens the endometrium and helps women with very thin linings or moderate to severe intrauterine adhesions become more fertile.
-
Efsubaglutide alfa for weight loss after metabolic surgery
This trial will test whether efsubaglutide alfa helps people who remain obese six months after metabolic surgery lose weight and improve obesity-related health problems.
-
First-line QL1706 combined with lenvatinib and AG for advanced metastatic pancreatic cancer
This trial will test whether combining QL1706, lenvatinib, and gemcitabine plus nab‑paclitaxel (AG) works better as first-line treatment for people with advanced metastatic pancreatic cancer who have not had prior therapy.
-
Disitamab vedotin plus abiraterone for HER2-expressing metastatic castration-resistant prostate cancer
This trial tests whether adding the antibody–drug conjugate disitamab vedotin to abiraterone helps men with HER2-expressing metastatic castration-resistant prostate cancer.
-
GLP-1/GCG dual agonist (mazdutide) for people with type 2 diabetes and early dementia
This study will test whether weekly injections of mazdutide can help thinking and memory in people aged 50–75 who have type 2 diabetes and early dementia.
-
Using ctDNA to guide capecitabine maintenance after pancreatic cancer surgery
This project tests whether blood ctDNA (MRD) can guide giving capecitabine as maintenance after standard adjuvant chemotherapy for people with resectable pancreatic cancer.
-
Proline Plus Empagliflozin tablets for treating type 2 diabetes
This study will try Proline Plus Empagliflozin tablets in adults with type 2 diabetes to see how well and how safely they work during routine care.
-
Combining radiotherapy or surgery with intense hormone therapy for advanced prostate cancer
This study is testing if combining surgery or radiation with strong hormone therapy can help men with newly diagnosed advanced prostate cancer feel better and live longer.
-
Assessing the effects of IL-17 inhibitors on hidden inflammation in psoriasis patients
This study is testing if IL-17 inhibitors can help reduce hidden inflammation in adults with moderate to severe psoriasis who aren't getting enough relief from their current treatments.
-
Ketorolac to improve outcomes and prognosis in Stanford Type A aortic dissection
This trial will test whether giving ketorolac around emergency surgery helps adults (18–65) with Stanford Type A aortic dissection recover better and have fewer complications over 90 days.
-
Using hydromorphone to treat acute chest pain
This study tests if hydromorphone can help people with severe chest pain feel better and recover faster.
-
Universal anti-CD70 CAR-T (CHT101) treatment for relapsed, treatment-resistant systemic lupus (SLE)
This trial will try a universal anti-CD70 CAR-T cell therapy (CHT101) in adults with relapsed or treatment-resistant systemic lupus (SLE).
-
Evaluating exosome multiomics and clinical outcomes in sudden cardiac death patients
This study looks at how certain tiny particles in the blood are connected to sudden cardiac death in patients who had symptoms before their heart stopped, to help improve future care and prevention.
-
Using natural killer cells from patients to improve fertility and pregnancy outcomes
This study is testing whether using a special type of immune cell from patients can help improve fertility and pregnancy outcomes for those struggling with infertility or past pregnancy issues.
-
Combining low-dose radiotherapy with chemotherapy for advanced gastric cancer treatment
This study is testing a new treatment combining low-dose radiation and chemotherapy for adults with advanced stomach cancer that hasn't improved with earlier treatments to see if it helps them feel better.
-
Olfactory Network Testing with Electro-acupuncture for Subjective Cognitive Decline
This study tests whether electro-acupuncture can help people aged 55–79 with subjective cognitive decline, by looking at changes in their brain’s smell-related networks.
-
Using probiotics with enteral nutrition to reduce infections after pancreatic surgery
This study is testing if adding probiotics to the feeding plan after pancreatic surgery can help reduce infections in patients.
-
Using patients' own T cells to treat Type 1 Diabetes
This study is testing whether using patients' own T cells can help treat Type 1 Diabetes by restoring the immune system's ability to protect insulin-producing cells.
-
Liposomal irinotecan and 5‑FU with a PD‑L1 blocker plus an anti‑angiogenic pill, with or without focused radiation, for second‑line metastatic pancreatic cancer
This study will try combining liposomal irinotecan and 5‑FU with a PD‑L1 blocker and an oral anti‑angiogenic drug, with or without targeted radiation, in people whose metastatic pancreatic cancer has progressed after first‑line chemotherapy.
-
Early diagnosis and intervention for cognitive dysfunction in diabetes patients
This study is trying to find early signs of thinking problems in people over 45 with Type 2 diabetes to help them get better care.
-
Identifying early signs of Alzheimer's disease using advanced imaging and biomarker analysis
This study is trying to find early signs of Alzheimer's disease in people who are at risk, using advanced brain scans and blood tests to help with earlier diagnosis and treatment.
-
Using Ferumoxytol for MRI in Atherosclerosis Patients
This study is testing if Ferumoxytol can be safely used as a contrast agent during MRI scans to help people with atherosclerosis get better images of their blood vessels.
-
Comparing two treatments for locally advanced pancreatic cancer
This study is testing two different treatment combinations for people with locally advanced pancreatic cancer to see which one works better.
-
Robot-guided minimally invasive surgery for large basal ganglia hemorrhage
This trial will test whether robot-assisted endoscopic surgery helps adults with large basal ganglia hemorrhages recover better than traditional open surgical approaches.
-
Using liraglutide to prevent delirium in elderly diabetic patients after heart surgery
This study is testing if liraglutide can help prevent confusion after heart surgery in older diabetic patients.
-
Combining salvage radiotherapy and androgen deprivation therapy with rezvilutamide for prostate cancer recurrence
This study is testing if adding a new drug called rezvilutamide to hormone therapy and radiation can help men whose prostate cancer has come back after surgery.
-
Comparing two surgical procedures for esophagogastric junction cancer
This study is testing whether a new surgical method for treating esophagogastric junction cancer helps patients recover better and have fewer complications than the traditional surgery.
-
Colchicine's effect on inflammation during cardiac surgery
This study is testing if colchicine can help reduce inflammation and improve recovery for people aged 50 to 80 who are having heart surgery.
-
Postoperative treatment for high-risk non-clear renal cell carcinoma
This study is testing if a combination of two medications can help prevent the return of non-clear renal cell carcinoma in patients who have just had surgery to remove their tumor.
-
Investigating risk factors for liver inflammation and fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease
This study is trying to find out what factors can increase the risk of liver inflammation and scarring in people with chronic hepatitis B and non-alcoholic fatty liver disease.
-
Combining tislelizumab with chemotherapy for advanced head and neck tumors
This study is testing if combining a new immune treatment called tislelizumab with chemotherapy can help people with advanced head and neck tumors feel better and improve their treatment outcomes.
-
Using rezvilutamide for prostate cancer recurrence after surgery
This study is testing if a new drug called rezvilutamide, used with hormone therapy and radiation, can help men whose prostate cancer has come back after surgery.
-
Tislelizumab combined with chemoradiotherapy for advanced gastric cancer
This study is testing if combining the immunotherapy drug Tislelizumab with chemoradiotherapy can help people with advanced stomach cancer do better before or after surgery compared to standard treatments.
-
Observing outcomes in patients with chronic hepatitis B in an indeterminate phase
This study is trying to learn more about patients with chronic hepatitis B who are in a tricky stage of their illness to see how their condition changes and if they might need treatment.
-
Intense hormone therapy before surgery for advanced prostate cancer
This study is testing whether a stronger hormone treatment before surgery can help men with advanced prostate cancer do better than the usual hormone therapy.
-
Electrical acupuncture for treating incontinence after prostate surgery
This study is testing if electrical acupuncture can help men who have trouble controlling their urine after prostate surgery feel better.
-
Observational study on chronic Hepatitis B infection in Jiangsu
This study is collecting information from people with chronic Hepatitis B in Jiangsu, China, to see what factors might affect their health outcomes.
Quick answers
How many clinical trials run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School are recruiting right now?
59, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 16, Phase 3: 4, Phase 1: 4, Phase 1/2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.